Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents
Launched by AALBORG UNIVERSITY · Mar 1, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different types of strength training exercises can help young people who have successfully completed treatment for leukemia or lymphoma. It includes children and adolescents aged 10 to 19 years who have been cancer-free for at least a year. Participants will be randomly divided into two groups: one will engage in a 16-week program focused on strength training with weights and machines, called STEEL, while the other will participate in circuit training that uses body weight and other tools like exercise balls.
Before starting, both the young participants and their parents will receive important information about potential long-term effects of cancer treatment, along with guidance on diet, sleep, and exercise. Throughout the trial, the researchers will check how these training programs affect the young people's quality of life, muscle strength, and other health measures. To be eligible, participants must be within the specified age range and be at least a year out of treatment, but they should not have any serious medical conditions or be involved in other similar research studies. This trial aims to provide valuable insights into how exercise can support the health and well-being of young cancer survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ten to 19 years of age at the point of inclusion
- • A minimum of 12 months since the last chemotherapy with no upper limit
- • Ability to understand the physical intervention and general participant advice
- Exclusion Criteria:
- • Participation in another research study that includes similar treatment
- • Pregnancy
- • Cardiac arrhythmia during exercise
- • Psychological disorders interfering with treatment
- • Presence of a clinical condition that needs immediate treatment
- • Planned surgeries within the subsequent 12 months that may interfere with performing exercises
- • Any contraindications to performing physical exercise as evaluated by the recruiting medical doctor
About Aalborg University
Aalborg University is a leading research institution based in Denmark, renowned for its innovative approach to education and research in engineering, natural sciences, and health sciences. With a commitment to advancing knowledge and improving public health outcomes, Aalborg University actively engages in clinical trials that explore cutting-edge medical solutions and interventions. The university fosters interdisciplinary collaboration, leveraging its expertise to enhance clinical research methodologies and contribute to the development of evidence-based practices in healthcare. Through its rigorous scientific inquiry and dedication to ethical standards, Aalborg University plays a pivotal role in shaping the future of health research and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Odense, , Denmark
Copenhagen, , Denmark
århus, , Denmark
Gistrup, , Denmark
Patients applied
Trial Officials
Pascal Madeleine, DSc
Study Chair
Aalborg University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported